Michael Belkin

Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery

Michael S. Conte, Dennis F. Bandyk, Alexander W. Clowes et al. · Journal of Vascular Surgery · 2006 · 634 citations · Full text

Venous Disease, Cardiovascular Disease, Vascular Surgery +7

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

Michael J. Mann, Anthony D. Whittemore, Magruder C. Donaldson et al. · The Lancet · 1999 · 400 citations

Translational Medicine, Gene Therapies, Transplantation +13

Technical factors affecting autogenous vein graft failure: Observations from a large multicenter trial

Andres Schanzer, Nathanael D. Hevelone, Christopher Owens et al. · Journal of Vascular Surgery · 2007 · 249 citations

Venous Disease, Technical Factors, Arterial Reconstructions +6

Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: Phase I study results

Nachshon Knoller, Gustavo Auerbach, Valentin Fulga et al. · Journal of Neurosurgery Spine · 2005 · 239 citations

Embolism from vertebral artery origin occlusive disease

L.R. Caplan, Pierre Amarenco, Axel J. Rosengart et al. · Neurology · 1992 · 187 citations

Thrombosis, Pulmonary Embolism, Vertebral Artery +14